Seiji Shigekawa

CD44 expression in the tumor periphery predicts the responsiveness to bevacizumab in the treatment of recurrent glioblastoma

Masahiro Nishikawa, Akihiro Inoue, Takanori Ohnishi et al. · Cancer Medicine · 2021 · 26 citations · Full text

Medicine, Cancer Biology, Oncology +17

Hypoxia-induced phenotypic transition from highly invasive to less invasive tumors in glioma stem-like cells: Significance of CD44 and osteopontin as therapeutic targets in glioblastoma

Masahiro Nishikawa, Akihiro Inoue, Takanori Ohnishi et al. · Translational Oncology · 2021 · 26 citations · Full text

Medicine, Cell Biology, Oncology +17

Met-PET uptake index for total tumor resection: identification of 11C-methionine uptake index as a goal for total tumor resection including infiltrating tumor cells in glioblastoma

Akihiro Inoue, Takanori Ohnishi, Shohei Kohno et al. · Neurosurgical Review · 2020 · 20 citations

Medicine, Nuclear Medicine, Oncology +13

Tricks and traps of ICG endoscopy for effectively applying endoscopic transsphenoidal surgery to pituitary adenoma

Akihiro Inoue, Shohei Kohno, Takanori Ohnishi et al. · Neurosurgical Review · 2020 · 20 citations

Medicine, Neurosurgery, Surgery +13

Quantitative measurement of peritumoral concentrations of glutamate, N-acetyl aspartate, and lactate on magnetic resonance spectroscopy predicts glioblastoma-related refractory epilepsy

Yawara Nakamura, Akihiro Inoue, Masahiro Nishikawa et al. · Acta Neurochirurgica · 2022 · 17 citations · Full text

Life Sciences, Neurology, Neuroscience +13